3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Terminated
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Conditions
Breast Neoplasms
29
Neoplasms
12
Lung Neoplasms
11
Endometrial Neoplasms
11
Stomach Neoplasms
10
Lymphatic Metastasis
7
Head and Neck Neoplasms
7
Melanoma
6
Esophageal Neoplasms
6
Carcinoma, Hepatocellular
6
Uterine Cervical Neoplasms
5
Colonic Neoplasms
5
Carcinoma, Non-Small-Cell Lung
5
Rectal Neoplasms
4
Ovarian Neoplasms
4
Sarcoma
3
Prostatic Neoplasms
3
Lymphedema
3
Colorectal Neoplasms
3
Brain Neoplasms
3
Vulvar Neoplasms
2
Squamous Cell Carcinoma of Head and Neck
2
Solitary Pulmonary Nodule
2
Sarcoma, Ewing
2
Rhabdomyosarcoma
2
Peritoneal Neoplasms
2
Osteosarcoma
2
Multiple Pulmonary Nodules
2
Margins of Excision
2
Giant Cell Tumor of Bone
2
Interventions
Pemetrexed
9
Nivolumab
8
Cisplatin
8
Carboplatin
8
pembrolizumab
7
130-nm albumin-bound paclitaxel
7
Gemcitabine
6
padeliporfin
5
durvalumab
5
Paclitaxel
5
Bevacizumab
5
palbociclib
4
napabucasin
4
atezolizumab
4
Irinotecan
4
Fulvestrant
4
Fluorouracil
4
Cyclophosphamide
4
ribociclib
3
osimertinib
3
cobimetinib
3
alectinib
3
abemaciclib
3
Trastuzumab
3
Sunitinib
3
Radiosurgery
3
Drug Therapy
3
Docetaxel
3
Cetuximab
3
Anastrozole
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Neoplasms by Site
×
Indocyanine Green
×
Clear all
NCT02111824
2021-09-17
MIMIG
The Methodist Hospital Research Institute
Phase 1
Terminated
7 enrolled